Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Toft

Showing results (41-50 of 129) with videos related to

Pageof 13
Sort By:
Frontiers in Neurology|May 13, 2025
Repeatability, reliability, and stability of eye movement measurements in Parkinson's disease, cerebellar ataxia, and healthy adultsSolveig E J Dalbro, Ahmed Elsais, Siri Lynne Rydning, et al.
BMC Neurology|June 7, 2014
Long-term follow-up of thalamic deep brain stimulation for essential tremor - patient satisfaction and mortalityMari Naumann Børretzen, Silje Bjerknes, Terje Sæhle, et al.
Annals of Neurology|April 27, 2005
Clinical features of LRRK2-associated Parkinson's disease in central NorwayJan O Aasly, Mathias Toft, Ignacio Fernandez-Mata, et al.
Scientific Reports|January 13, 2021
Allele-specific expression of Parkinson's disease susceptibility genes in human brainMargrete Langmyhr, Sandra Pilar Henriksen, Chiara Cappelletti, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 13, 2008
[Treatment of movement disorders with deep brain stimulation]Mathias Toft, Bård Lilleeng, Jon Ramm-Pettersen, et al.
NPJ Parkinson'S Disease|October 31, 2023
Epigenome-wide association study of peripheral immune cell populations in Parkinson's diseaseMaren Stolp Andersen, Ingvild Sørum Leikfoss, Ina Skaara Brorson, et al.
Movement Disorders Clinical Practice|January 10, 2022
Subthalamic Nucleus Stimulation in Parkinson's Disease: 5-Year Extension Study of a Randomized TrialSilje Bjerknes, Mathias Toft, Reidun Brandt, et al.
Archives of Neurology|September 13, 2006
Clinical heterogeneity of the LRRK2 G2019S mutationSpiridon Papapetropoulos, Carlos Singer, Owen A Ross, et al.
Mechanisms of Ageing and Development|August 10, 2005
LRRK2 mutations are not common in Alzheimer's diseaseMathias Toft, Sigrid Botne Sando, Stacey Melquist, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 21, 2023
Lysosomal Polygenic Burden Drives Cognitive Decline in Parkinson's Disease with Low Alzheimer RiskJon-Anders Tunold, Manuela M X Tan, Mathias Toft, et al.
Pageof 13

Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
Frontiers in Neurology|May 13, 2025
Repeatability, reliability, and stability of eye movement measurements in Parkinson's disease, cerebellar ataxia, and healthy adultsSolveig E J Dalbro, Ahmed Elsais, Siri Lynne Rydning, et al.
BMC Neurology|June 7, 2014
Long-term follow-up of thalamic deep brain stimulation for essential tremor - patient satisfaction and mortalityMari Naumann Børretzen, Silje Bjerknes, Terje Sæhle, et al.
Annals of Neurology|April 27, 2005
Clinical features of LRRK2-associated Parkinson's disease in central NorwayJan O Aasly, Mathias Toft, Ignacio Fernandez-Mata, et al.
Scientific Reports|January 13, 2021
Allele-specific expression of Parkinson's disease susceptibility genes in human brainMargrete Langmyhr, Sandra Pilar Henriksen, Chiara Cappelletti, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 13, 2008
[Treatment of movement disorders with deep brain stimulation]Mathias Toft, Bård Lilleeng, Jon Ramm-Pettersen, et al.
NPJ Parkinson'S Disease|October 31, 2023
Epigenome-wide association study of peripheral immune cell populations in Parkinson's diseaseMaren Stolp Andersen, Ingvild Sørum Leikfoss, Ina Skaara Brorson, et al.
Movement Disorders Clinical Practice|January 10, 2022
Subthalamic Nucleus Stimulation in Parkinson's Disease: 5-Year Extension Study of a Randomized TrialSilje Bjerknes, Mathias Toft, Reidun Brandt, et al.
Archives of Neurology|September 13, 2006
Clinical heterogeneity of the LRRK2 G2019S mutationSpiridon Papapetropoulos, Carlos Singer, Owen A Ross, et al.
Mechanisms of Ageing and Development|August 10, 2005
LRRK2 mutations are not common in Alzheimer's diseaseMathias Toft, Sigrid Botne Sando, Stacey Melquist, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 21, 2023
Lysosomal Polygenic Burden Drives Cognitive Decline in Parkinson's Disease with Low Alzheimer RiskJon-Anders Tunold, Manuela M X Tan, Mathias Toft, et al.
Pageof 13